![Royston Glasspool](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Royston Glasspool
Director/Board Member at
RELMADA THERAPEUTICS, INC.
Net worth: - $ as of 30/05/2026
Profile
Royston John Glasspool is Chief Executive Officer at VarmX BV since 2024.
Holds director roles at Biotechnology Innovation Organization and Relmada Therapeutics, Inc. since 2019.
Serves as Venture Partner at Agent Capital LLC since 2018.
Former Chief Executive Officer & Director at Anthos Therapeutics, Inc. from 2019 to 2024.
Former Independent Director at DalCor Pharmaceuticals Canada, Inc. from 2017 to 2023.
Former EVP, Head-Corporate Strategy & Customer Operations at Baxalta, Inc. from 2015 to 2017.
Former VP-Emerging Therapies & Market Development at Baxter BioScience Corp.
from 2012 to 2015.
Former Head-Europe Region, Vaccines & Diagnostics at Novartis AG from 2009 to 2012.
Former Director & Vice President at European Vaccine Manufacturers from 2010 to 2012.
Education includes undergraduate degrees from Staffordshire University and Oxford Brookes University, and a graduate degree from Tufts University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 25/03/2026 | 0 ( -.--% ) | - $ | 30/05/2026 |
Royston Glasspool active positions
| Companies | Position | Start |
|---|---|---|
| RELMADA THERAPEUTICS, INC. | Director/Board Member | 18/12/2019 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Director/Board Member | - |
Agent Capital LLC
 Agent Capital LLC Investment ManagersFinance Agent Capital invests in companies located in the United States. The firm targets companies operating in the fields of therapeutics sectors and industries. It provides financing for seed, early, late stage, crossover and PIPE stage requirements. The firm acts as a lead investor and also makes co-investments. | Private Equity Investor | 31/12/2017 |
Varmx BV
 Varmx BV BiotechnologyHealth Technology Develops and manufactures therapeutic proteins to restore hemostasis | Chief Executive Officer | 30/09/2024 |
Former positions of Royston Glasspool
| Companies | Position | End |
|---|---|---|
Anthos Therapeutics, Inc.
 Anthos Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutic options for the treatment of cardiovascular metabolic diseases | Chief Executive Officer | 21/04/2024 |
DalCor Pharmaceuticals Canada, Inc.
 DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Develops precision treatments for cardiovascular disease | Director/Board Member | 31/12/2022 |
| BAXALTA INC | Corporate Officer/Principal | 31/12/2016 |
Baxter BioScience Corp.
 Baxter BioScience Corp. BiotechnologyHealth Technology Provides biopharmaceutical and vaccines services | Corporate Officer/Principal | 31/05/2015 |
European Vaccine Manufacturers | Director/Board Member | 30/11/2012 |
Training of Royston Glasspool
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
66
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Baxalta, Inc.
 Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Oxford Brookes University
 Oxford Brookes University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Staffordshire University
 Staffordshire University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Provides biopharmaceutical and vaccines services | Health Technology |
European Vaccine Manufacturers | |
Relmada Therapeutics, Inc.
 Relmada Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products for the treatment of depression and other central nervous system diseases | Health Technology |
DalCor Pharmaceuticals Canada, Inc.
DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Develops precision treatments for cardiovascular disease | Health Technology |
Varmx BV
Varmx BV BiotechnologyHealth Technology Develops and manufactures therapeutic proteins to restore hemostasis | Health Technology |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital invests in companies located in the United States. The firm targets companies operating in the fields of therapeutics sectors and industries. It provides financing for seed, early, late stage, crossover and PIPE stage requirements. The firm acts as a lead investor and also makes co-investments. | Finance |
Anthos Therapeutics, Inc.
Anthos Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutic options for the treatment of cardiovascular metabolic diseases | Health Technology |
- Stock Market
- Insiders
- Royston Glasspool
